GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers
Zantac settlement must still be approved by individual plaintiffs, but is expected to resolve vast majority of cancer lawsuits filed in state courts.
Tag Archives: GlaxoSmithKline
-
-
Delaware Zantac Lawsuits Continue To Be Filed As GlaxoSmithKline Appeals to State Supreme Court
Drug maker is challenging a lower court ruling, which allows Zantac lawsuits in Delaware to move forward to trial over the increased risk of cancer caused by the recalled heartburn medication.
-
GSK Gets Expert Witness Excluded in Zantac Cancer Lawsuit in Florida Before Trial
Florida ruling does not directly impact other Zantac lawsuits filed against GlaxoSmithKline in other state courts, each involving claims that former users were not adequately warned about the cancer risks that led to a 2020 recall.
-
Jury Rejects Claim That Zantac Caused Colorectal Cancer Diagnosis of Illinois Woman
Defense verdict comes as GSK faces several additional Zantac trials in Florida, Pennsylvania and Nevada in the coming months, each raising similar allegations that the recalled heartburn drug caused cancer to develop in former users.
-
GSK Continues To Settle Zantac Lawsuits Before Trial, While Maintaining Heartburn Drug Did Not Cause Cancers
Despite agreeing to a number of individual Zantac lawsuit settlements and issuing a massive Zantac recall in 2020, GSK continues to argue that there is no evidence the recalled heartburn drug caused cancers among users.
-
Federal Appeals Court Returns Zantac Cancer Lawsuits Back To Connecticut State Court
Judges noted that the nine Zantac lawsuits involving more than 850 plaintiffs were structured in a way to avoid the need for the cases to be handled at the federal level, where all similar claims have been dismissed.
-
Zantac Lawsuits in Delaware State Court Cleared To Move Forward
Nearly 75,000 lawsuits over cancer caused by Zantac can proceed, after Delaware state court judge found that plaintiffs' expert witness testimony was sufficient for a jury to consider the claims
-
Jury Rejects Claim That Zantac Caused Cancer Diagnosis in First Bellwether Trial
Verdict comes in a Zantac lawsuit against GlaxoSmithKline and Boehringer Ingelheim, weeks after Sanofi and Pfizer announced agreements to settle thousands of Zantac cancer claims.
-
Zantac Cancer Risks Concealed By GlaxoSmithKline for Decades, Whistleblower Lawsuit Alleges
Glaxo first discovered a link between NDMA in Zantac and cancer at least four decades ago, according to the lawsuit filed by the independent testing lab that uncovered the cancer risks associated with the heartburn drug
-
Pfizer Zantac Settlement Payouts Will Total Up to $250M for Users Diagnosed with Cancer: Reports
GlaxoSmithKline reportedly faces the bulk of the remaining Zantac cancer lawsuits, with the first case of more than 70,000 claims currently going before a jury in Chicago.
